Advertisement Pharmaceutical Business review - Page 3351 of 5285 -
Pharmaceutical Business review is using cookies

ContinueLearn More
Close
August 13, 2026

Remepy secures $36m funding for hybrid drug pipeline expansion

Remepy has closed a $36m Series A financing round to accelerate its pharmaceutical co-development partnerships and expand its hybrid drug pipeline.

Continue
Remepy develops hybrid drugs through partnerships with pharmaceutical companies. Credit: Gorodenkoff / Shutterstock.com.
August 12, 2026

Mereo BioPharma and Sentynl Therapeutics sign licensing deal for alvelestat

Alvelestat is designed to inhibit neutrophil elastase, an enzyme linked to inflammation and lung tissue damage. Credit: NMK-Studio / Shutterstock.com.
August 12, 2026

Alfasigma signs agreement to acquire Nordic Group

The acquisition will bring Nordic Pharma’s rheumatoid arthritis business into Alfasigma’s portfolio. Credit: Stock-Asso / Shutterstock.com.

Contracts

January 23, 2025

Kamada to supply immune globulin products in Latin America

KAMRAB must be administered alongside a complete rabies vaccine regimen. Credit: Nappy on Unsplash.

Bavarian Nordic secures $156.8m US vaccine deal

Boehringer Ingelheim receives EC conditional marketing approval for spesolimab

Marinus Pharmaceuticals signs collaboration agreement with Tenacia Biotechnology

Deals

Deals January 20, 2025

Fermion and Simcere to partner on development of pain treatment drug

Pharmaceutical Business Review

WuXi Biologics and Sino Biopharm collaborate on monoclonal antibody discovery

Merck enhances ophthalmology portfolio with EyeBio acquisition

Biocon signs licensing and supply deal for diabetes drug in Brazil

Popular

  1. BeOne and Revolution Medicines partner for oncology therapies
  2. Jazz Pharmaceuticals to acquire Actio Biosciences for $820m upfront
  3. Innovent and Daiichi Sankyo sign deal for Vanflyta in China
  4. Energenesis and Taiwan Tanabe to develop ENERGI-F703DFU for DFUs
  5. Mediar and Ono Pharmaceutical to develop fibro-inflammatory treatments

PRESS RELEASES

SCHOTT Pharma Expands Portfolio for Sensitive Biologics with cartriQ® BioPure
SCHOTT Pharma Expands Portfolio for Sensitive Biologics with cartriQ® BioPure
Pharmaceutical Business Review
SCHOTT Pharma and Nemera Deliver Verified Pen Injector Platform with Sterile Cartridge System
SCHOTT Pharma Invests in Sterile Cartridge Production in Hungary
SCHOTT Pharma Invests in Sterile Cartridge Production in Hungary
SCHOTT Pharma Expands Ready-to-Use Portfolio with Sterile 1.5ml Cartridge
SCHOTT Pharma Expands Ready-to-Use Portfolio with Sterile 1.5ml Cartridge
Dr Imre Molnár Awarded With an Exceptional Scientific Honour – Tswett-Nernst European Award
Dr Imre Molnár Awarded With an Exceptional Scientific Honour – Tswett-Nernst European Award

Suppliers

Whitepapers

Smoothly Through the Production Process: EVERIC™ Strong/Smooth Test
Smoothly Through the Production Process: EVERIC™ Strong/Smooth Test
Strengths and Weaknesses of Different Prefilled Syringes for Injections in Hospitals: A Case Study by Niklas Niederwieser and Patrick Gallagher SCHOTT AG
Strengths and Weaknesses of Different Prefilled Syringes for Injections in Hospitals: A Case Study by Niklas Niederwieser and Patrick Gallagher SCHOTT AG
Tracking the Cracking: How to Optimise Pharma Fill-and-Finish Processes by Use of Strength Testing and Fractography
Tracking the Cracking: How to Optimise Pharma Fill-and-Finish Processes by Use of Strength Testing and Fractography